The Patent Finder

Centrient Pharmaceuticals Netherlands B.V.

Also on record
Records under this name other than the patents Centrient Pharmaceuticals Netherlands B.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.

Showing 1 to 4 of 4 · Back to Centrient Pharmaceuticals Netherlands B.V.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,828,411Method for isolating caspofungin
Lapsed on the fee record
Ended Nov 28, 2025 · USPTO record
Lapsed on the fee recordEnded Nov 28, 2025USPTO record
US 9,556,233Cyclohexapeptide
Lapsed on the fee record
Ended Jan 31, 2025 · USPTO record
Lapsed on the fee recordEnded Jan 31, 2025USPTO record
US 9,676,729Amine salts of pitavastatin and rosuvastatin
Lapsed on the fee record
Ended Jun 13, 2021 · USPTO record
Lapsed on the fee recordEnded Jun 13, 2021USPTO record
US 9,630,906Amine salts of pitavastatin and rosuvastatin
Lapsed on the fee record
Ended Apr 25, 2021 · USPTO record
Lapsed on the fee recordEnded Apr 25, 2021USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited